임상시험 공급 및 물류 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Clinical Trial Supply & Logistics Market size is expected to reach USD 10050.04 Million in 2034 from USD 4814.82 Million (2025) growing at a CAGR of 8.52% during 2026-2034.

The Global Clinical Trial Supply & Logistics Market is expanding rapidly due to the increasing number of clinical trials worldwide. Pharmaceutical and biotechnology companies are investing heavily in research and development to launch new drugs and vaccines. Proper storage, packaging, and transportation of clinical trial materials are critical, which drives demand for specialized logistics services.

The growth of personalized medicine and biologics has further increased the complexity of clinical trials. Temperature-sensitive drugs require advanced cold chain logistics, which has boosted investment in modern supply systems. Regulatory compliance and strict quality standards also push companies to partner with professional logistics providers. The rise in global collaborations and multi-center trials supports additional growth.

In the future, digital technologies such as real-time tracking and data analytics will enhance transparency and efficiency in clinical supply chains. The increasing use of decentralized trials and home-based participation will create new logistical needs. Emerging markets are also expected to contribute significantly as research activities expand. Overall, the market has strong long-term growth potential.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Service

• Logistics & Distribution
• Storage & Retention
• Packaging, Labeling, and Blinding
• Manufacturing
• Comparator Sourcing
• Other Services

By Phase

• Phase I
• Phase II
• Phase III
• Phase IV

By Therapeutic Area

• Oncology
• Cardiovascular Diseases
• Respiratory Diseases
• CNS and Mental Disorders
• Others

By End Use

• Pharmaceuticals
• Biologicals
• Medical Device

COMPANIES PROFILED

• Thermo Fisher Scientific Inc, UPS Healthcare, Piramal Pharma Solutions, DHL, Parexel International, Almac Group, Movianto, UDG Healthcare, FedEx, Catalent Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET: BY SERVICE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Service
• 4.2. Logistics & Distribution Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Storage & Retention Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Packaging, Labeling, and Blinding Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Manufacturing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Comparator Sourcing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Other Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET: BY PHASE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Phase
• 5.2. Phase I Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Phase II Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Phase III Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Phase IV Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET: BY THERAPEUTIC AREA 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Therapeutic Area
• 6.2. Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Cardiovascular Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Respiratory Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. CNS and Mental Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET: BY END USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End Use
• 7.2. Pharmaceuticals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Biologicals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Medical Device Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Service
  • 8.2.2 By Phase
  • 8.2.3 By Therapeutic Area
  • 8.2.4 By End Use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Service
  • 8.3.2 By Phase
  • 8.3.3 By Therapeutic Area
  • 8.3.4 By End Use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Service
  • 8.4.2 By Phase
  • 8.4.3 By Therapeutic Area
  • 8.4.4 By End Use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Service
  • 8.5.2 By Phase
  • 8.5.3 By Therapeutic Area
  • 8.5.4 By End Use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Service
  • 8.6.2 By Phase
  • 8.6.3 By Therapeutic Area
  • 8.6.4 By End Use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Thermo Fisher Scientific Inc
  • 10.2.2 UPS Healthcare
  • 10.2.3 Piramal Pharma Solutions
  • 10.2.4 DHL
  • 10.2.5 Parexel International
  • 10.2.6 Almac Group
  • 10.2.7 Movianto
  • 10.2.8 UDG Healthcare
  • 10.2.9 FedEx
  • 10.2.10 Catalent Inc